Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-Aquaporin 4 antibodies.
Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients.
Myelination of the nervous system: mechanisms and functions.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis.
Vivitrol dosing and administration
Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
Assessing walking disability in multiple sclerosis.
Central motor conduction time may predict response to fampridine in patients with multiple sclerosis.
Glial contributions to neural function and disease.
Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.
Young Researchers in Life Sciences Meeting 2012
Zebrafish screen identifies novel compound with selective toxicity against leukemia.
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Early pathological alterations of lower lumbar cords detected by ultrahigh-field MRI in a mouse multiple sclerosis model.
The occurrence of dystonia in upper-limb multiple sclerosis tremor.
Revisiting brain atrophy and its relationship to disability in multiple sclerosis.
Safety and Tolerability of Glatiramer Acetate (GLACIER)
Magnetic Resonance Spectroscopy Markers of Disease Progression in Multiple Sclerosis.
Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.
Simvastatin shows promise in treating progressive multiple sclerosis, study finds.
Client-centred therapy in multiple sclerosis: More intensive diagnostic evaluation and less intensive treatment.

Pages